PharmAsia News
July 9, 2013
Executive Summary
The drug regulators of seven nations are cooperating in keeping on top of an explosion in the demand for generic drugs by making sure production facilities are inspected and international standards met.
The drug regulators of seven nations are cooperating in keeping on top of an explosion in the demand for generic drugs by making sure production facilities are inspected and international standards met. The seven regulators include Australia's Therapeutic Goods Administration, Brazil's Anvisa, Health Canada, The European Medicines Agency, the U.K.'s Medicine and Healthcare Product Regulatory Agency, the U.S. FDA and the World Health Organization. Working as a group, they either pool their resources for inspections or share findings from their own inspections involving new drug approvals. India, the world's largest maker of generics, is becoming the group's largest area for cooperative operations.
Executive Summary
The drug regulators of seven nations are cooperating in keeping on top of an explosion in the demand for generic drugs by making sure production facilities are inspected and international standards met.
The drug regulators of seven nations are cooperating in keeping on top of an explosion in the demand for generic drugs by making sure production facilities are inspected and international standards met. The seven regulators include Australia's Therapeutic Goods Administration, Brazil's Anvisa, Health Canada, The European Medicines Agency, the U.K.'s Medicine and Healthcare Product Regulatory Agency, the U.S. FDA and the World Health Organization. Working as a group, they either pool their resources for inspections or share findings from their own inspections involving new drug approvals. India, the world's largest maker of generics, is becoming the group's largest area for cooperative operations.